novartis glp 1 drug Novo Nordisk's oral GLP-1 didn't work on Alzheimer's as hoped, but don't call it a failure Novartis, Alector, Merck, Alnylm, UniQure

In the SUSTAIN 6 trial, over 3,297 patients with type 2 diabetes with established chronic kidney disease and/or cardiovascular disease underwent randomization to semaglutide or placebo and were followed for 2 years resulting in a 26% risk reduction in the combined endpoint of rate of cardiovascular disease, nonfatal myocardial infarction, or nonfatal stroke [47]

GLP-1 may also affect hunger centers in the brain, which impacts appetite regulation and reduces hunger

The hormones tell the pancreas to secrete more and higher amounts of insulin (the hormone that reduces blood sugar)

Treating obesity isn't just about weight lossit's about preserving health while losing weight

Obinwanne, K

In this context, the aim of the present document is to summarize, in the form of a narrative literature review, the currently available data on the main mechanisms of action of GIP/GLP-1 co-agonists and the clinical effects of tirzepatide evaluated in various clinical trials